{"id":"W1976209099","doi":"10.1007/s11095-013-1259-1","title":"Current Challenges in Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products","year":2014,"lang":"en","type":"review","venue":"Pharmaceutical Research","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"ca_institutions":"FSD Pharma (Canada)","funders":"American Association of Pharmaceutical Scientists","keywords":"Bioequivalence; Pharmaceutical industry; Risk analysis (engineering); Quality (philosophy); Quality by Design; Management science; Regulatory science; Product (mathematics); Computer science; Medicine; New product development; Business; Pharmacology; Engineering; Bioavailability; Marketing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00176174,0.0002067308,0.0005414046,0.0001453756,0.00007616535,0.0000335376,0.000440701,0.0002914084,0.000002385702],"category_scores_gemma":[0.0004827703,0.0001598076,0.00009867592,0.0001744638,0.0003094104,0.000002346226,0.0003605312,0.000691801,0.000004285582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003356541,"about_ca_system_score_gemma":0.0002686997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002447572,"about_ca_topic_score_gemma":0.00001213291,"domain_scores_codex":[0.9978868,0.000197552,0.000383513,0.0007574871,0.0002740128,0.0005006786],"domain_scores_gemma":[0.9990212,0.0003303793,0.00004809512,0.0003971999,0.0001101951,0.00009295311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001104695,0.0001990424,0.00001036251,0.01153458,0.00002985727,3.285332e-7,0.000002239225,3.625301e-8,0.0009021316,0.02319324,0.0001743836,0.9639428],"study_design_scores_gemma":[0.0002943823,0.00008823965,0.00004736317,0.0007097487,0.00003786566,0.000006239451,0.00001103043,0.00001276015,0.0002845462,0.0003998776,0.9979209,0.0001870439],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004680377,0.9948295,0.0008564454,0.002389172,0.00006245106,0.001450914,0.0001169703,0.00001902676,0.00022871],"genre_scores_gemma":[0.002077179,0.9957235,0.0006197262,0.00000859991,0.0001977214,0.001193862,0.0001193818,0.00002151893,0.00003848096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9977465,"threshold_uncertainty_score":0.6516765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7074066587856508,"score_gpt":0.6422555944921446,"score_spread":0.06515106429350614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}